Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    FDA grants drug orphan designation for treatment of malaria

    Author:
    HT Staff
    Publish date: November 9, 2017

    The US Food and Drug Administration (FDA) has granted orphan drug designation to artemisone, a product candidate for the treatment of malaria....

    • Read More

    News

    EMA grants accelerated assessment to drug for AML

    Author:
    HT Staff
    Publish date: November 9, 2017

    The European Medicines Agency’s Committee for Medicinal Products for Human Use has granted accelerated assessment to a marketing authorization...

    • Read More

    News

    Drug receives orphan designation for treatment of PNH

    Author:
    HT Staff
    Publish date: November 9, 2017

    The US Food and Drug Administration (FDA) has granted orphan drug designation to ACH-4471 for the treatment of paroxysmal nocturnal hemoglobinuria...

    • Read More

    News

    Ferric citrate approved to treat iron-deficiency anemia

    Author:
    HT Staff
    Publish date: November 8, 2017

    The US Food and Drug Administration (FDA) has approved ferric citrate (Auryxia) to treat iron-deficiency anemia in adults with chronic kidney...

    • Read More

    News

    FDA lifts hold on trials of universal CAR T-cell therapy

    Author:
    HT Staff
    Publish date: November 8, 2017

    The US Food and Drug Administration (FDA) has lifted the full clinical hold on 2 phase 1 studies of UCART123, an allogeneic chimeric antigen...

    • Read More

    News

    FDA approves first treatment for ECD

    Author:
    HT Staff
    Publish date: November 7, 2017

    The US Food and Drug Administration (FDA) has expanded the approved use of vemurafenib (Zelboraf) to include the treatment of adults who have...

    • Read More

    News

    FDA approves wider use of hematology analyzer

    Author:
    HT Staff
    Publish date: November 7, 2017

    The US Food and Drug Administration (FDA) has expanded the approved use of the XW-100 Automated Hematology Analyzer. The analyzer can now be used...

    • Read More

    News

    Intervention improves well-being in AYAs with cancer

    Author:
    HT Staff
    Publish date: November 7, 2017

    SAN DIEGO—New research suggests an intervention can improve psychosocial health in adolescents and young adults (AYAs) living with cancer. The...

    • Read More

    News

    Cancer drug costs increasing despite competition

    Author:
    HT Staff
    Publish date: November 6, 2017

    Cancer drug costs in the US increase substantially after launch, regardless of competition, according to a study published in the Journal of...

    • Read More

    News

    Protein may be target for enhancing HSC transplants

    Author:
    HT Staff
    Publish date: November 5, 2017

    Targeting the protein Del-1 could potentially improve hematopoietic stem cell (HSC) transplants, according to researchers. The team found that...

    • Read More

    News

    Product can improve joint health in hemophilia A

    Author:
    HT Staff
    Publish date: November 4, 2017

    New research suggests prophylaxis with a recombinant factor VIII Fc fusion protein (rFVIIIFc) can improve joint health over time in patients with...

    • Read More

    News

    Team identifies HSCs that rapidly reconstitute hematopoiesis

    Author:
    HT Staff
    Publish date: November 3, 2017

    Researchers say they have identified a subpopulation of hematopoietic stem cells (HSCs) that immediately contributes to long-term, multilineage...

    • Read More

    News

    FDA grants product breakthrough designation for MM

    Author:
    HT Staff
    Publish date: November 3, 2017

    The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to GSK2857916, an anti-B-cell maturation antigen (BCMA)...

    • Read More

    News

    Cancer patients prefer computer-free interactions

    Author:
    HT Staff
    Publish date: November 3, 2017

    SAN DIEGO—A new study suggests patients with advanced cancer may prefer doctors who do not use a computer while communicating with them. Most of...

    • Read More

    News

    Study reveals misperceptions among AML patients

    Author:
    HT Staff
    Publish date: November 2, 2017

    SAN DIEGO—A study of acute myeloid leukemia (AML) patients has revealed misperceptions about treatment risks and the likelihood of cure....

    • Read More

    Pages

    • « first
    • …
    • 38
    • 39
    • 40
    • 41
    • 42
    • 43
    • 44
    • 45
    • 46
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery